We recently compiled a list of the These 10 Firms Were Last Week’s Worst Performers. In this article, we are going to take a ...
Janney Montgomery Scott LLC lowered its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 21.0% in the fourth quarter, ...
(CN) — A federal judge has temporarily blocked an expected $4 billion slash to funding for biomedical research after a group ...
(CN) — A coalition of 22 state attorneys general is taking aim at a Trump administration policy that would slash funding for ...
The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.
To come up with last week’s worst performers, we considered only the stocks with at least $2 billion in market capitalization ...
The fourth-quarter earnings season for the biotech sector is in full swing this week. A few bigwigs have already reported results. Among these, Bristol Myers reported better-than-expected ...
On Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA ...
Un desarrollador inmobiliario de ciencias de la vida de seis años de antigüedad ha incrementado su portafolio en San Diego con la reciente compra de un campus de investigación renovado de tres ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback